Pulse Biosciences, Inc. (PLSE:NASDAQ) closed at $53.29 on November 6, 2026, up 0.41% on the day. The stock trades 9.5% below its 52-week high of $58.90 and 324.3% above its 52-week low of $12.56. Over the past year, it gained 244.7%. Pulse Biosciences, Inc. is part of the Health Care sector (Medical/Dental Instruments).
In 252 trading sessions since November 6, 2025, PLSE closed higher on 132 days (52%). Its best day was February 6, 2026 (+51.57%) and its worst was February 20, 2026 (-14.59%). The stock moved 10% or more in a single session 9 times.
Pulse Biosciences, Inc., a development stage medical device company, focuses on developing medical technologies based on sub-microsecond pulsed electric field technology to detect and treat skin cancer and enhance wound healing. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is based in Burlingame, California.
Find more stocks like PLSE with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.